Table: Torii Pharmaceutical - Q1 parent results
Apr 25 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2025 Mar 31, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 14.68 13.45 64.70
(+9.2 pct) (+13.9 pct) (+7.1 pct)
Operating 1.70 1.38 4.10
(+23.2 pct) (-39.7 pct)
Recurring 1.86 1.17 4.50
(+59.5 pct) (-35.0 pct)
Net 1.39 878 mln 3.40
(+58.4 pct) (-32.6 pct)
EPS 49.51 yen 31.27 yen 120.95 yen
Ann Div 120.00 yen 120.00 yen
-Q2 div 60.00 yen 60.00 yen
-Q4 div 60.00 yen 60.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)